Data from DELIVER and ACHIEVE Clinicals Trial to be Presented -- Presentation on ACHIEVE Trial in DM1 and Company Symposium to Feature Data on ...

The Institute of Chemical Technology, Mumbai, in collaboration with the Mumbai Biocluster, successfully hosted the 5th Annual ...

More information about the 2025 AAAAI / WAO Joint Congress can be accessed here.

Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapies designed specifically for patients with ...

Emphasising the importance of clinical laboratory results in medical decision-making, Dr. Sadanand Naik, a cardiologist from ...

The Patron-in-Chief of the conference will be SU acting Vice-Chancellor Prof. Dr. Khalil-ur-Rehman Khoumbati, while the ...

Chantal Stieber earns the Presidential Award for Excellence in Science, Mathematics and Engineering Mentoring.

Recursion is advancing REC-617, a promising reversible, non-covalent CDK7 inhibitor, showing potential in treating advanced solid tumors with positive interim phase 1 data. Read more here.

AMRITSAR: The second day of 28th Punjab Science Congress (PSC-2025) and National Conference on “Current Trends in Science and ...

NORWOOD, Mass. - Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP), a $119 million market cap biopharmaceutical company, announced the release of an abstract detailing its Phase 1 clinical study of ...

First real-world outcomes data for ADSTILADRIN® (nadofaragene firadenovec-vncg) to be presented at 2025 ASCO Genitourinary ...